resTORbio, Inc.. (TORC) NASDAQ
$2.28 0 (0.00%)
Market Cap: $83.11M
As of 09/15/20 04:00 PM EDT. Market closed.
resTORbio, Inc.. (TORC) NASDAQ
$2.28 0 (0.00%)
Market Cap: $83.11M
As of 09/15/20 04:00 PM EDT. Market closed.
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, ... read more
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Chen Schor
Full Time Employees
18
CEO Compensation (Base)
$443,201
CEO Compensation (Total)
$3.09M
Sector
Health Technology
Industry
Biotechnology
CEO
Chen Schor
Full Time Employees
18
CEO Compensation (Base)
$443,201
CEO Compensation (Total)
$3.09M
URL
Address
500 Boylston Street, MA, Boston, 02116.
PRICE CHART
From:
To:
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0.86 - $10.50
Volume
0
Avg. Volume (30 days)
386,196
Market Cap
$83.11M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
36,453,900
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0.86 - $10.50
Volume
0
Avg. Volume (30 days)
386,196
Market Cap
$83.11M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
36,453,900
Open in:
Open in:
INSIDER TRANSACTIONS FOR RESTORBIO, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Galimi Francesco | SVP & Chief Medical Officer | Apr 01, 2022 | Option Exercise | $5.97 | 7,621 | 45,497 | 67,538 | Apr 05, 2022, 06:23 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Apr 04, 2022 | Option Exercise | $13.91 | 7,979 | 110,956 | 65,953 | Apr 05, 2022, 06:23 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Apr 01, 2022 | Sale | $21.00 | 7,621 | 160,041 | 59,917 | Apr 05, 2022, 06:23 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Apr 04, 2022 | Sale | $21.00 | 7,979 | 167,559 | 59,917 | Apr 05, 2022, 06:23 PM |
| Jakobovits Aya | Director | Mar 09, 2022 | Sale | $14.00 | 4,000 | 56,000 | 356,345 | Mar 11, 2022, 04:08 PM |
| Jakobovits Aya | Director | Feb 16, 2022 | Sale | $14.83 | 4,000 | 59,328 | 358,345 | Feb 17, 2022, 06:10 PM |
| Healey Don | Chief Technology Officer | Feb 14, 2022 | Option Exercise | $14.27 | 5,533 | 78,956 | 52,934 | Feb 16, 2022, 09:41 PM |
| Aftab Blake | Chief Scientific Officer | Feb 14, 2022 | Option Exercise | $14.27 | 5,533 | 78,956 | 52,903 | Feb 16, 2022, 09:40 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Feb 14, 2022 | Option Exercise | $14.27 | 5,533 | 78,956 | 59,917 | Feb 16, 2022, 09:36 PM |
| Harvey Brian Nicholas | Chief Financial Officer | Feb 14, 2022 | Option Exercise | $14.27 | 4,696 | 67,012 | 54,608 | Feb 16, 2022, 09:33 PM |
| Schor Chen | President & CEO | Feb 14, 2022 | Option Exercise | $14.27 | 21,288 | 303,780 | 149,424 | Feb 16, 2022, 09:31 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Jan 28, 2022 | Option Exercise | $11.69 | 5,533 | 64,681 | 49,450 | Feb 01, 2022, 08:50 PM |
| Healey Don | Chief Technology Officer | Jan 28, 2022 | Option Exercise | $11.69 | 5,533 | 64,681 | 42,467 | Feb 01, 2022, 08:48 PM |
| Aftab Blake | Chief Scientific Officer | Jan 28, 2022 | Option Exercise | $11.69 | 5,564 | 65,043 | 42,436 | Feb 01, 2022, 08:44 PM |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 28, 2022 | Option Exercise | $11.69 | 4,696 | 54,896 | 43,304 | Feb 01, 2022, 08:42 PM |
| Schor Chen | President & CEO | Jan 28, 2022 | Option Exercise | $11.69 | 21,288 | 248,857 | 122,712 | Feb 01, 2022, 08:40 PM |
| GORDON CARL L | Director | Dec 10, 2021 | Option Exercise | $14.00 | 214,285 | 2,999,990 | 242,285 | Dec 14, 2021, 07:06 PM |
| ORBIMED ADVISORS LLC | Director | Dec 10, 2021 | Option Exercise | $14.00 | 214,285 | 2,999,990 | 242,285 | Dec 14, 2021, 06:41 PM |
| Sinclair Andrew | Director | Dec 08, 2021 | Buy | $14.00 | 500,000 | 7,000,000 | 2,115,385 | Dec 13, 2021, 06:00 PM |
| Sinclair Andrew | Director | Dec 08, 2021 | Buy | $14.00 | 500,000 | 7,000,000 | 2,140,721 | Dec 10, 2021, 05:30 PM |
| Schor Chen | President & CEO | Jun 16, 2021 | Sale | $10.53 | 16,466 | 173,443 | 89,836 | Jun 21, 2021, 04:25 PM |
| Jakobovits Aya | Director | Jun 15, 2021 | Sale | $11.16 | 3,847 | 42,919 | 215,883 | Jun 17, 2021, 06:08 PM |
| Galimi Francesco | SVP & Chief Medical Officer | Jun 04, 2021 | Option Exercise | $5.97 | 6,983 | 41,689 | 6,983 | Jun 08, 2021, 09:35 PM |
| Schor Chen | President & CEO | May 19, 2021 | Sale | $13.45 | 16,466 | 221,436 | 108,533 | May 21, 2021, 04:34 PM |
| Schor Chen | President and CEO | Apr 20, 2021 | Sale | $12.01 | 16,466 | 197,676 | 125,764 | Apr 22, 2021, 04:34 PM |
| Schor Chen | President and CEO | Apr 06, 2021 | Sale | $13.04 | 16,466 | 214,700 | 134,746 | Apr 08, 2021, 04:37 PM |
| Schor Chen | President and CEO | Mar 30, 2021 | Sale | $12.85 | 16,466 | 211,640 | 149,128 | Apr 01, 2021, 06:48 PM |
| Schor Chen | President and CEO | Mar 16, 2021 | Sale | $15.34 | 16,466 | 252,558 | 155,218 | Apr 01, 2021, 06:43 PM |
| Schor Chen | President and CEO | Mar 16, 2021 | Sale | $15.34 | 16,466 | 252,558 | 155,218 | Mar 18, 2021, 09:55 PM |
| Chimovits Erez | Director | Feb 12, 2021 | Option Exercise | $13.00 | 524,349 | 6,816,537 | 5,243,259 | Feb 18, 2021, 09:44 PM |
| GORDON CARL L | Director | Feb 12, 2021 | Option Exercise | $13.00 | 524,349 | 6,816,537 | 5,243,259 | Feb 18, 2021, 09:41 PM |
| ORBIMED ADVISORS LLC | Director | Feb 12, 2021 | Option Exercise | $13.00 | 524,349 | 6,816,537 | 5,243,259 | Feb 18, 2021, 09:38 PM |
| PureTech Health LLC | 10% Owner | Dec 18, 2019 | Sale | $1.20 | 6,161,531 | 7,393,837 | 2,119,696 | Dec 19, 2019, 05:26 PM |
| PureTech Health LLC | 10% Owner | Dec 13, 2019 | Sale | $1.24 | 205,763 | 255,805 | 8,281,227 | Dec 17, 2019, 06:27 PM |
| PureTech Health LLC | 10% Owner | Dec 12, 2019 | Sale | $1.25 | 385,884 | 482,316 | 8,486,990 | Dec 12, 2019, 05:59 PM |
| PureTech Health LLC | 10% Owner | Dec 11, 2019 | Sale | $1.25 | 59,921 | 74,901 | 8,872,874 | Dec 12, 2019, 05:59 PM |
| PureTech Health LLC | 10% Owner | Dec 10, 2019 | Sale | $1.26 | 336,561 | 423,663 | 8,932,795 | Dec 12, 2019, 05:59 PM |
| PureTech Health LLC | 10% Owner | Nov 15, 2019 | Sale | $1.25 | 531,040 | 661,941 | 9,269,356 | Nov 19, 2019, 04:25 PM |
| Schor Chen | President and CEO | Apr 16, 2018 | Buy | $8.95 | 2,000 | 17,907 | 1,892,363 | Apr 17, 2018, 08:08 AM |
| Schor Chen | President and CEO | Apr 11, 2018 | Buy | $9.36 | 2,000 | 18,724 | 1,890,363 | Apr 12, 2018, 07:32 AM |
| Schor Chen | President and CEO | Apr 10, 2018 | Buy | $8.46 | 2,000 | 16,915 | 1,888,363 | Apr 11, 2018, 08:06 AM |
| SILVERSTEIN JONATHAN | Director | Jan 30, 2018 | Buy | $15.00 | 533,333 | 7,999,995 | 4,830,387 | Jan 30, 2018, 06:42 PM |
| ORBIMED ADVISORS LLC | Director | Jan 30, 2018 | Buy | $15.00 | 533,333 | 7,999,995 | 4,830,387 | Jan 30, 2018, 06:41 PM |
| PureTech Health LLC | 10% Owner | Jan 30, 2018 | Buy | $15.00 | 233,333 | 3,499,995 | 9,800,396 | Jan 30, 2018, 06:37 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Galimi Francesco | SVP & Chief Medical Officer | 04/01/2022 | 45,497 |
| Galimi Francesco | SVP & Chief Medical Officer | 04/04/2022 | 110,956 |
| Galimi Francesco | SVP & Chief Medical Officer | 04/01/2022 | 160,041 |
| Galimi Francesco | SVP & Chief Medical Officer | 04/04/2022 | 167,559 |
| Jakobovits Aya | Director | 03/09/2022 | 56,000 |
| Jakobovits Aya | Director | 02/16/2022 | 59,328 |
| Healey Don | Chief Technology Officer | 02/14/2022 | 78,956 |
| Aftab Blake | Chief Scientific Officer | 02/14/2022 | 78,956 |
| Galimi Francesco | SVP & Chief Medical Officer | 02/14/2022 | 78,956 |
| Harvey Brian Nicholas | Chief Financial Officer | 02/14/2022 | 67,012 |
| Schor Chen | President & CEO | 02/14/2022 | 303,780 |
| Galimi Francesco | SVP & Chief Medical Officer | 01/28/2022 | 64,681 |
| Healey Don | Chief Technology Officer | 01/28/2022 | 64,681 |
| Aftab Blake | Chief Scientific Officer | 01/28/2022 | 65,043 |
| Harvey Brian Nicholas | Chief Financial Officer | 01/28/2022 | 54,896 |
| Schor Chen | President & CEO | 01/28/2022 | 248,857 |
| GORDON CARL L | Director | 12/10/2021 | 2,999,990 |
| ORBIMED ADVISORS LLC | Director | 12/10/2021 | 2,999,990 |
| Sinclair Andrew | Director | 12/08/2021 | 7,000,000 |
| Sinclair Andrew | Director | 12/08/2021 | 7,000,000 |
| Schor Chen | President & CEO | 06/16/2021 | 173,443 |
| Jakobovits Aya | Director | 06/15/2021 | 42,919 |
| Galimi Francesco | SVP & Chief Medical Officer | 06/04/2021 | 41,689 |
| Schor Chen | President & CEO | 05/19/2021 | 221,436 |
| Schor Chen | President and CEO | 04/20/2021 | 197,676 |
| Schor Chen | President and CEO | 04/06/2021 | 214,700 |
| Schor Chen | President and CEO | 03/30/2021 | 211,640 |
| Schor Chen | President and CEO | 03/16/2021 | 252,558 |
| Schor Chen | President and CEO | 03/16/2021 | 252,558 |
| Chimovits Erez | Director | 02/12/2021 | 6,816,537 |
| GORDON CARL L | Director | 02/12/2021 | 6,816,537 |
| ORBIMED ADVISORS LLC | Director | 02/12/2021 | 6,816,537 |
| PureTech Health LLC | 10% Owner | 12/18/2019 | 7,393,837 |
| PureTech Health LLC | 10% Owner | 12/13/2019 | 255,805 |
| PureTech Health LLC | 10% Owner | 12/12/2019 | 482,316 |
| PureTech Health LLC | 10% Owner | 12/11/2019 | 74,901 |
| PureTech Health LLC | 10% Owner | 12/10/2019 | 423,663 |
| PureTech Health LLC | 10% Owner | 11/15/2019 | 661,941 |
| Schor Chen | President and CEO | 04/16/2018 | 17,907 |
| Schor Chen | President and CEO | 04/11/2018 | 18,724 |
| Schor Chen | President and CEO | 04/10/2018 | 16,915 |
| SILVERSTEIN JONATHAN | Director | 01/30/2018 | 7,999,995 |
| ORBIMED ADVISORS LLC | Director | 01/30/2018 | 7,999,995 |
| PureTech Health LLC | 10% Owner | 01/30/2018 | 3,499,995 |
Load More Insider Transactions